Altrinsic Global Advisors LLC Gilead Sciences, Inc. Transaction History

Altrinsic Global Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $2.61 Million - $3.27 Million	-45,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $3.05 Million - $3.29 Million	-45,000 Reduced 50.0%	45,000 $3.14 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.83 Million - $3.23 Million	50,000 Added 125.0%	90,000 $5.24 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $1.24 Million - $1.56 Million	20,000 Added 100.0%	40,000 $2.53 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $1.45 Million - $1.68 Million	20,000 New	20,000 $1.54 Million

1,917

995M

10.1M

9.46M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.